It is well known that nucleic acid extracted from certain viruses is infectious in vitro and in vivo 1, but represents only a small fraction of the infectivity of the whole virus. While a number of workers have been able to enhance infectivity of viral ribonucleic acid in vitro by the use of a number of agents including dimethylsulfoxide (DM SO)2-7, no studies have been re ported which show enhanced intact virus infectivity.
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In view of the increasing interest in the therapeutic value of D M SO 8' 9, it was considered mandatory to determine the safety of DMSO adm inistration in the presence of viral infection or immunization with live virus. The present studies have conclusively shown that sustained topical adm inistration of DMSO-carbopol gel did not adversely affect the course of three experimen tal virus infections in animals.
The various host species were treated topically with 80% pharmaceutical grade DMSO (gelled with neutra lized carbopol 940) at a dose level of approximately 1.0mg/gm of body weight. Treatm ent consisted of rub bing the dose of gel gently into the skin daily before and/or after challenge with intact virus. Suitable pla cebo gels were used to control all experiments. In ad dition, a water-treated group was included to deter mine the effect of daily manipulation.
Three nearly identical experiments were carried out to ascertain the potential effect of DMSO on influenza virus infection in mice. In all experiments DMSO, placebo or water was applied daily to the abdomen of mice for one week before and also for two weeks after challenge with virus (15 m ice/group). The mice were infected via the intranasal route with varying doses from 0.04 -1.6 minimum lethal dose, 50% endpoint (MLD50) . Mortality of animals was recorded as a func tion of time. A composite of the results of all experi ments (post-infection days 7 and 13) is presented in Table 1 . All data (survival rates on post-infection days 5, 7, 9, 11, 13) were subsequently analyzed by (a) fit ting an exponential to the data and by (b) regression analysis10, n . No significant differences (95% con fidence limit) in survival rates between water, placebo and DMSO-treated groups was shown.
In order to study the effect of DMSO on Semliki Forest virus infection, a similar series of experiments as cited above were carried out. The mice were in fected by intraperitoneal injection with varying doses from 0.17 to 17 MLD50 of Semliki Forest virus. The rate of death of the animals was the criterion for com parison. Representative data were analyzed in the same manner as those for the influenza studies and are re corded in Table 1 . Again, no significant differences (95% confidence limit) in survival rates among the various groups were shown. In the third group of experiments twelve New7 Zea land rabbits were sheared and the dorsal surface of each divided into right and left halves. One side of each animal received an intraderm al injection (at five different sites) of 0.1 ml of vaccinia virus dilution con taining 21 rabbit infecting doses, 50% endpoint (RID50)*Iml or 0.1m l of saline. The virus (Lederle Strain) was diluted in m/15 Sorensen buffer (pH 7.2) containing 400 units of pencillin and 400 meg streptomycin/ml in order to prevent bacterial infection. On the same or opposite side, several sites were treated with DMSO gel, placebo gel or water on each day of treatment.
Virus-induced lesions were read daily and evaluated with respect to (1) and (2) lesion score.
In experiment # 1, DMSO, placebo or water was applied daily for one week before and one week after challenge with virus. In experiment $ 2, the grouping of rabbits and agents used was essentially the same as in the first study with the exception that 210 RID50 virus challenge was followed by daily treatm ent for one week. The resulting data were analyzed by two-way analyses of variance 11 to test for difference between experiments, difference between groups and existence of interaction between experiments and treatments. In addition, comparison of difference between groups and of varying the site of virus infection were analyzed by means of S t u d e n t's T test n . While discernible lesions appeared consistently within two days after injection of virus, no significant difference in lesions of DMSO, placebo or water-treated animals was showrn.
The present studies represent to our knowledge the first experimental attem pt to determine the effect of DMSO on virus infection in vivo. The results, obtained in test systems carefully selected to this end, and validated by complete statistical analysis, show that topical administration of 80% DMSO-carbopol gel did not adversely affect the course of experimental (a) in fluenza A (PR-8) or Semliki Forest virus infection in mice or (b) vaccinia virus infection in rabbits.
